BACTIQ — Bactiquant A/S Income Statement
0.000.00%
Last trade - 00:00- DKK61.09m
- DKK49.92m
- DKK12.30m
Annual income statement for Bactiquant A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | DAS | DAS | DAS | DAS | DAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 15.5 | 5.48 | 8.36 | 12.4 | 12.3 |
| Cost of Revenue | |||||
| Gross Profit | 8.61 | 3.22 | -2.95 | -1.15 | -0.756 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 11.7 | 6.9 | 21 | 26.2 | 24.1 |
| Operating Profit | 3.82 | -1.42 | -12.7 | -13.8 | -11.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3.96 | -1.42 | -13.4 | -14.2 | -13.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.18 | -1.11 | -13.6 | -14.2 | -13.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 3.18 | -1.11 | -13.6 | -14.2 | -13.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.18 | -1.11 | -13.6 | -14.2 | -13.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.143 | -0.036 | -0.712 | -0.712 | -0.591 |